FDA Alerts and Recalls
The mandatory scan identified materially active notices. Consumers should discard or return recalled food as directed; clinicians should quarantine affected injectable products and follow manufacturer/FDA device instructions. Adverse-event reports alone would not establish causation.
What changed
Everything Sprouts/Calco alfalfa sprouts were added August 22; several August 21 device early alerts remained materially active.
Why it matters
Contaminated food, injectable particulates and medical-device failures can cause serious harm if products remain in use.
What to watch next
FDA enforcement classifications, recall effectiveness checks, termination status and updated harm reports.
What we know
- Everything Sprouts LLC recalled Everything Sprouts and Calco alfalfa sprouts on August 22 for potential Salmonella and STEC contamination; class, lot identifiers and confirmed harm counts were not displayed in the scan result.
- B. Braun Medical voluntarily recalled Excel Lactated Ringers Injection 1000 mL on August 19 over particulate matter including cellulose fibers and polystyrene; the FDA page is an FDA-posted company announcement.
- FDA posted August 21 medical-device early alerts involving Medline breathing circuits, GE HealthCare Portrait Mobile monitoring software and Medical Action Industries epidural kits; FDA was collecting information.
- GE HealthCare ApexPro CTS correction record Z-2242-2026 covered 476 units distributed worldwide and instructed alternate bedside monitoring if persistent NO COMM or OFF NETWORK conditions occurred.
Material unknowns
- Recall-class assignment for recent food notices
- Exact lots for all products
- Confirmed illness, injury and death denominators
U.S. strategic assessment
High interestFDA transparency enables mitigation, but an FDA-posted company announcement is not identical to an independently verified FDA causation finding.
Objectives
- Remove or correct unsafe products
- Notify consumers and clinicians
- Verify effectiveness of corrective action
Strategy
- Company recalls
- FDA posting and classification
- Medical-device early alerts and corrections
Outcomes
- Multiple active notices posted
- No complete harm denominator available for several notices
Risks
- Exposure before product removal
- Incomplete lot identification
- Underreported harms
- Device monitoring interruption
Sources
01Recall list and status baseline
Device-alert status
Identifiers, quantity, distribution and action
Company-announced voluntary recall posted by FDA
Outbreak and downstream recall scope
Independent health-news cross-check